Inspire Medical Systems: Investors Should Sleep Better From Here Onwards

Group 1 - The core viewpoint is that the risk-reward proposition for Inspire Medical (NYSE: INSP) has improved due to lagging shares, profitability, and FDA approval for a new device [1] - Inspire Medical's business has become profitable, indicating a positive shift in financial performance [1] - The company received FDA approval for a new device, which is expected to enhance its market position and growth potential [1] Group 2 - The investing group "Value In Corporate Events" focuses on identifying opportunities in IPOs, mergers & acquisitions, earnings reports, and corporate capital allocation changes [2] - The group covers approximately 10 major events each month to find the best investment opportunities [2]